Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Non-comparative, Multicentre, Phase IV Study to Evaluate the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

NCT01373567 is registered in ClinicalTrials.gov with Piramal Enterprises Limited as lead sponsor.

NCT NCT01373567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01373567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Non-comparative, Multicentre, Phase IV Study to Evaluate the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis
Lead sponsor
Piramal Enterprises Limited
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2010
Completion date
June 30, 2012
Enrollment
298 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis